⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study
globenewswire.com
TLX
Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX
globenewswire.com
TLX
TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action
globenewswire.com
TLX
FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026
businesswire.com
TLX
Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX
prnewswire.com
TLX
Pomerantz LLP Notifies Investors of Class Action Filing Against Telix Pharmaceuticals Limited – TLX
accessnewswire.com
TLX
TLX DEADLINE - FINAL REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Telix Pharmaceuticals Limited Investors to Participate in the Class Action Lawsuit
accessnewswire.com
TLX
TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today’s Lead Plaintiff Deadline in Securities Class Action
globenewswire.com
TLX
TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX
businesswire.com
TLX
TLX DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm - TLX
accessnewswire.com
TLX